A Northwestern Medicine study has expanded the understanding of nicotine’s influences on the brain’s reward pathway, with implications for the development of anti-addiction therapies.
A team of scientists has uncovered the precise cells that flow into and harm the lung soon after a transplant. The study, published in The Journal of Clinical Investigation, may lead to drug therapies that target the destructive cells.
A team of scientists has discovered that in children with epilepsy thought to be caused by a spontaneous mutation, about 10 percent of parents in fact carry the same variant in a small proportion of their own cells.
Genetic mutations dysregulating synapse function contribute to a toxic cascade that leads to neurodegeneration in Parkinson’s disease, according to a Northwestern Medicine study.
Northwestern Medicine scientists have discovered an epigenetic imbalance that can lead to cancer, and used these findings to inhibit tumors in models.
Drugs commonly used to prevent HIV transmission from mother to child during pregnancy were not associated with a higher risk of adverse birth outcomes, according to a new study.
Northwestern Medicine scientists have discovered a new compound that halts the spread of multiple types of cancer cells.
Stuart H. Orkin, MD, an investigator of the Howard Hughes Medical Institute at Boston Children’s Hospital and Dana-Farber Cancer Institute and a professor at Harvard Medical School, is the recipient of the 2018 Mechthild Esser Nemmers Prize in Medical Science at Northwestern University.
On May 6, the Illinois Precision Medicine Consortium hosted a launch event at Chicago’s Millennium Park, one of many simultaneous events held around the country to mark the program’s launch.
NewCures at Northwestern University is a novel accelerator working to identify promising potential therapies in development, fund research into their viability, and promote their development as new drugs.